Zhou, Zhichao <br/><br/>
Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.  [electronic resource] 

 -  Cancer  Oct 2005 
 - 1713-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.21383  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Apoptosis--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--diagnostic imaging<br/>Cell Proliferation--drug effects<br/>Diphosphonates--therapeutic use<br/>Drug Therapy, Combination<br/>Enzyme-Linked Immunosorbent Assay<br/>Glycoproteins--metabolism<br/>Humans<br/>Imidazoles--therapeutic use<br/>Immunoenzyme Techniques<br/>Mice<br/>Mice, Nude<br/>Osteoclasts--cytology<br/>Osteoprotegerin<br/>Paclitaxel--therapeutic use<br/>Radiography<br/>Receptors, Cytoplasmic and Nuclear--metabolism<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sarcoma, Ewing--diagnostic imaging<br/>Zoledronic Acid